These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 6145143

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. A new variant form of hypertyrosinaemia due to 4-hydroxyphenylpyruvic acid oxidase deficiency.
    Endo F, Kitano A, Uehara I, Nagata N, Matsuda I, Shinka T, Kuhara T, Matsumoto I.
    J Inherit Metab Dis; 1982; 5(4):237-8. PubMed ID: 6133038
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Different molecular basis for fumarylacetoacetate hydrolase deficiency in the two clinical forms of hereditary tyrosinemia (type I).
    Tanguay RM, Valet JP, Lescault A, Duband JL, Laberge C, Lettre F, Plante M.
    Am J Hum Genet; 1990 Aug; 47(2):308-16. PubMed ID: 2378356
    [Abstract] [Full Text] [Related]

  • 6. [The metabolic basis of the hyperphenylalaninemias and tyrosinemia].
    Shintaku H.
    Nihon Rinsho; 1992 Jul; 50(7):1542-7. PubMed ID: 1357201
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Deficient fumarylacetoacetate fumarylhydrolase activity in lymphocytes and fibroblasts from patients with hereditary tyrosinemia.
    Kvittingen EA, Halvorsen S, Jellum E.
    Pediatr Res; 1983 Jul; 17(7):541-4. PubMed ID: 6622096
    [Abstract] [Full Text] [Related]

  • 11. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B, Lindstedt S, Steen G.
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dietary treatment of tyrosinemia type I: importance of methionine restriction.
    Michals K, Matolon R, Wong PW.
    J Am Diet Assoc; 1978 Nov; 73(5):507-14. PubMed ID: 701680
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Microassay of tyrosine-amino transferase and p-hydroxyphenylpyruvic acid oxidase in mammalian liver and patients with hereditary tyrosinemia.
    Whelan DT, Zannoni VG.
    Biochem Med; 1974 Jan; 9(1):19-31. PubMed ID: 4150247
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different clinical forms of hereditary tyrosinemia (type I) in patients with identical genotypes.
    Poudrier J, Lettre F, Scriver CR, Larochelle J, Tanguay RM.
    Mol Genet Metab; 1998 Jun; 64(2):119-25. PubMed ID: 9705236
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.